Characteristics and Prognosis of Patients With Non‐Syndromic Sensorineural Hearing Loss Associated With Myo15a Mutations
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1200 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2025. Written by Yueying Wang and 8 co-authors. Institution: Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China. Major MEDLINE topics: Hearing Loss, Sensorineural, Mutation, Myosins. 15 references. Funded by: Guangdong Natural Science Foundation, Guangzhou Science and Technology Planning Project.
Abstract (original language)
Objective
This study aims to investigate the characteristics of hearing loss associated with MYO15A mutations and to analyze the longitudinal prognosis over a 4‐year period using different treatment modalities, including cochlear implants (CIs), hearing aids (HAs), and conservative management. Study Design A retrospective case review.
Setting
A tertiary referral center.
Methods
Sequencing was performed to recruit patients with potentially pathogenic MYO15A mutation‐induced hearing loss. Audiological data, radiological imaging, and assessment of hearing and speech performance before and after different treatments were analyzed in combination with patients' genotypes.
Results
Sixteen patients with MYO15A mutation‐induced deafness from 14 unrelated pedigrees were enrolled, carrying 5 previously unreported mutations: c.3660_3666delinsAA (p.Glu1221fs), c.4635delG (p.Val1545fs), c.6664A>G (p.Met2222Val), c.8215delG (p.Ala2739fs), and c.8897delG (p.Gly2966fs). Inner ear malformations were observed in 3 patients. CI recipients exhibited significant improvements in hearing and speech abilities 1‐year post‐implantation, while individuals using HAs showed a gradual improvement trend over a 4‐year period. Notably, even those with bilateral cochlear aperture atresia achieved satisfactory hearing and speech outcomes following early CIs.
Conclusion
Patients with MYO15A mutations who underwent CIs generally demonstrated earlier improvements in hearing and speech development compared to those using HAs. Early genetic detection and timely implementation of assistive acoustic stimulation are recommended for optimal outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otorhinolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
- Institute of Otorhinolaryngology, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Funding
- Guangdong Natural Science Foundation
- Guangzhou Science and Technology Planning Project
Cite
APA
Wang, Y., Fang, S., Cen, X., Liang, Y., Chen, A., Huang, L., Wang, J., Xiong, G., & Chen, K. (2025). Characteristics and Prognosis of Patients With Non‐Syndromic Sensorineural Hearing Loss Associated With Myo15a Mutations. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1200
Vancouver
Wang Y, Fang S, Cen X, Liang Y, Chen A, Huang L, et al. Characteristics and Prognosis of Patients With Non‐Syndromic Sensorineural Hearing Loss Associated With Myo15a Mutations. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1200
BibTeX
@article{Wang2025,
author = {Wang, Yueying and Fang, Shubin and Cen, Xiaoqing and Liang, Yue and Chen, Anhai and Huang, Lusha and Wang, Juan and Xiong, Guanxia and Chen, Kaitian},
title = {Characteristics and Prognosis of Patients With Non‐Syndromic Sensorineural Hearing Loss Associated With Myo15a Mutations},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1200}
}
EUVIMED